Clinical trial
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Examine the Longer-Term Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Obese Subjects
NCT00645255 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Examine the Longer-Term Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Obese Subjects
- Lead sponsor
- Abbott
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 1998
- Completion date
- Not reported
- Enrollment
- 466 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.